NCT02025205View on ClinicalTrials.gov

Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

March 15, 2017

Conditions
COPD Patients With Homogeneous EmphysemaEndoscopic Lung Volume Reduction With Endobronchial Valve
Interventions
DEVICE

Endobronchial Valve

Endoscopic Lung Volume Reduction with Zephyr Endobronchial Valve

Trial Locations (8)

1140

Ludwig-Boltzmann-Institut für COPD und Pneumologische Epidemiologie, Vienna

13353

Charité Campus Virchow-Klinikum, Berlin

21075

Lungenabteilung Thoraxzentrum Hamburg, Hamburg

45239

Ruhrlandklinik, Westdeutsches Lungenzentrum, Essen

58675

Lungenklinik Hemer, Hemer

69126

Thoraxklinik am Universitäts klinikum Heidelberg, Heidelberg

90419

Klinikum Nürnberg Nord, Nuremberg

9700RB

Department of pulmonary dieases, University Medical Center, Groningen

All Listed Sponsors
lead

Pulmonx International Sàrl

INDUSTRY

NCT02025205 - Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study | Biotech Hunter | Biotech Hunter